BioNTech (BNTX)
(Real Time Quote from BATS)
$100.82 USD
+1.34 (1.35%)
Updated Jun 5, 2024 03:18 PM ET
3-Hold of 5 3
C Value F Growth F Momentum F VGM
Brokerage Reports
BioNTech SE Sponsored ADR [BNTX]
Reports for Purchase
Showing records 121 - 140 ( 154 total )
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
mRNA-1273 Gets FDA Green Light; Reiterate Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
BNT162b2 Potential Approval in Europe; Rival on Deck at FDA; Reiterate Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
FDA Grants BNT162b2 Emergency Use Authorization; Reiterate Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
With BNT162b2 U.K. Approval, Focus Now Shifts to FDA; Reiterate Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
BNT162b2 FDA Advisory Committee Next Month; Reiterate Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
BNT162b2 Interim Data Encouraging; Key Unknowns Remain; Reiterate Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
BNT162b2 Unavailable Until Post-Election; Competitor Safety Concerns; Reiterate Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
BNT162b2 Submissions Initiated; Vaccine Domain Updates; Reiterate Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
BioNTech to Receive Funding From German Government; Reiterate Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
BNT162 Phase 3 Trial Enrollment Expansion Planned; Reiterate Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
BNT162b2 Preclinical Data; Key Competitor Updates; Reiterate Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
BNT162b2 Has Similar Efficacy, Better Safety vs. BNT162b1; Reiterate Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
2Q20 Financial Results Reported; Reiterate Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
COVID-19 Vaccine Candidate Trial Starts in China; Reiterate Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
Supply Agreement Inked for Japan; FixVac Platform Advances; Reiterate Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
Moderna''s COVID-19 Vaccine Pricing Likely to Get Push Back, In Our View; Reiterate Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
Lead COVID-19 Vaccine Selected; Phase 2/3 Trial Initiated; Reiterate Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
Upsized Equity Offering Priced; Reiterate Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
United States Government Vaccine Purchase Agreement Inked; Reiterate Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
BNT162b1 German Data; Rival COVID-19 Vaccines Readout; Reiterate Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R